维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Lara P N Jr"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Phase Ⅱ trial of irinote-ean/cisplatin compared with etoposide/cisplatin in extersive-stage small-cen lung cancer:clinical and pharmarogenomic results from SWOG SO124 显示文摘	Lara P N Jr Natale R Crouley J	2009	J Clin Onco12009，27，15：	1
	2	Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive - stage small - cell lung cancer: clinical and pharmacogenomic results from SWOG S0124 显示文摘	Lara P N Jr Natale R Crowley J	2009	J Clin Oncol2009，27，15：	1
	3	Activity of high-dose toremifene plus cisplatin in platinumol/L-treated non-small-cell lung cancer:a phase Ⅱ california cancer consortiumol/L trial显示文摘	Lara Jr P N Gandara D R Longmate J	2001	Cancer Chemother Pharacol2001，48，：	1
	4	SU5416 plus inter- feron alpha in advanced renal cell carcinoma a phase imaging cor- relates of angiogenesis inhibition 显示文摘	LARA P N JR QUINN D I MARGOLIN K	2006	Clin Cancer Res2006，9，130：	1
	5	Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy显示文摘	VANSTEENKISTE J LARA P N Jr LE CHEVALIER T	2007	J Clin Oncol2007，25，23：	1
	6	Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer显示文摘	Petrylak D P Tangen C M Hussain M H Lara P N Jr Jones J A Taplin M E	2004	N Engl J Med2004，351，：	1
	7	Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer:results from Southwest Oncology Group randomized trials显示文摘	Lara P N Jr Redman M W Kelly K	2008	J Clin Oncol2008，26，3：	1
	8	Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for non-small cell lung cancer:exploring a new frontier显示文摘	SANGHA R LARA P N Jr MACK P C	2009	Curr Opin Oncol2009，21，2：	1
	9	Sorafenih with interferon alfa-2b as first line treatment of advanced renal carcinoma: a phase lI study of the Southwest Oncology Group 显示文摘	Ryan C W Goldman B H Lara P N Jr Mack P C Beer T M Tangen C M	2007	J Clin Oncol2007，25，：	1
	10	Phase Ⅲ trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer:clinical and pharmacogenomic results from SWOG S0124显示文摘	Lara P N Jr Natale R Crowley J	2009	J Clin Oncol2009，2027，15：	1
	11	Activity of high-dose toremifene plus cisplatin in platinum-treated non-small cell lung cancer: a phase Ⅱ California Cancer Consortium Trial 显示文摘	LARA P N JR GANDARA D R LONGMATE J	2001	Cancer Chemother Pharacol2001，48，1：	1
	12	Activity of high-doss toremifene plus cisplatin in platinum-treated non-small-cell lung cancer:a phase Ⅱ California Cancer Consortium Trial显示文摘	Lara P N Jr G andara D R Longmate J		0，，01：	1
	13	High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer:targeted plasma levels are achievable clinically显示文摘	Lara P N Jr Gandara D R Wurz G T		0，，06：	1
	14	Neoadjuvant therapy for non-small cell lung cancer显示文摘	Gandara D R Lara P N jr Goldberg Z	2001	Anticancer drugs2001，12，1：	1
	15	Trastuzumab plus Docetaxel in HER2/neu-Positive Non-Small-Cell Lung Cancer:A California Cancer Consortium Screening and Phase II Trial显示文摘	Lara P N Jr Laptalo L Longmate J	2004	Clin Lung Cancer2004，5，4：	1
	16	Detection of low level HER -2/neu gene amplification in prostate cancer by flu- orescence in situ hybridization 显示文摘	Liu H L Gandour - Edwards R Lara P N Jr	2001	Cancer J2001，7，5：	1
	17	SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase Ⅱ california cancer consortium Study with biological and imaging correlates of angiogenesis inhibition显示文摘	Lara P N Jr Quinn D I Margolin K	2003	Clin Cancer Res2003，9，13：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费